Ellen Rosenberg Amicus Therapeutics, Inc. (FOLD) insider trading activity

Ellen Rosenberg is Chief Legal Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 367,654 shares of FOLD, which is worth approximately $3.68 Million. The most recent transaction as insider was on Feb 07, 2024, when has been sold 29,600 shares (Common Stock) at a price of $13.0 per share, resulting in proceeds of $384,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 368K

0% 3M change

10.62% 12M change

Total Value Held $3.68 Million

Ellen Rosenberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 07 2024	SELL Open market or private sale	$384,800 $13.0 p/Share	29,600 Reduced 7.45%	367,654 Common Stock
Feb 07 2024	BUY Exercise of conversion of derivative security	$152,736 $5.16 p/Share	29,600 Added 6.93%	397,254 Common Stock
Feb 06 2024	SELL Open market or private sale	$5,200 $13.0 p/Share	400 Reduced 0.11%	367,654 Common Stock
Feb 06 2024	BUY Exercise of conversion of derivative security	$2,064 $5.16 p/Share	400 Added 0.11%	368,054 Common Stock
Jan 09 2024	SELL Payment of exercise price or tax liability	$163,800 $13.65 p/Share	12,000 Reduced 3.16%	367,654 Common Stock
Jan 04 2024	SELL Payment of exercise price or tax liability	$45,427 $13.44 p/Share	3,380 Reduced 0.88%	379,654 Common Stock
Jan 03 2024	SELL Payment of exercise price or tax liability	$208,321 $13.53 p/Share	15,397 Reduced 3.86%	383,034 Common Stock

Jan 02 2024	SELL Open market or private sale	$426,300 $14.21 p/Share	30,000 Reduced 8.06%	342,285 Common Stock
Jan 02 2024	SELL Payment of exercise price or tax liability	$99,466 $14.24 p/Share	6,985 Reduced 1.72%	398,431 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$154,800 $5.16 p/Share	30,000 Added 7.46%	372,285 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	63,131 Added 13.47%	405,416 Common Stock
Dec 27 2023	SELL Open market or private sale	$70,350 $14.07 p/Share	5,000 Reduced 1.44%	342,285 Common Stock
Dec 27 2023	BUY Exercise of conversion of derivative security	$25,800 $5.16 p/Share	5,000 Added 1.42%	347,285 Common Stock
Dec 26 2023	SELL Open market or private sale	$420,000 $14.0 p/Share	30,000 Reduced 8.06%	342,285 Common Stock
Dec 26 2023	BUY Exercise of conversion of derivative security	$154,800 $5.16 p/Share	30,000 Added 7.46%	372,285 Common Stock
Dec 18 2023	BUY Grant, award, or other acquisition	-	9,940 Added 2.82%	342,285 Common Stock
Jan 24 2023	SELL Open market or private sale	$424,095 $13.32 p/Share	31,839 Reduced 8.74%	332,345 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$290,703 $12.02 p/Share	24,185 Reduced 6.23%	364,184 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	56,024 Added 12.61%	388,369 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$43,007 $12.03 p/Share	3,575 Reduced 1.06%	332,345 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$94,163 $11.93 p/Share	7,893 Reduced 2.3%	335,920 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	77,749 Added 18.44%	343,813 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$178,791 $12.21 p/Share	14,643 Reduced 5.22%	266,064 Common Stock
Aug 01 2022	SELL Open market or private sale	$111,452 $10.02 p/Share	11,123 Reduced 3.81%	280,707 Common Stock
Jun 21 2022	SELL Open market or private sale	$111,220 $10.0 p/Share	11,122 Reduced 3.67%	291,830 Common Stock

Ellen Rosenberg

Chief Legal Officer

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account